FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and concerns a method of reducing size of ischemic-reperfusion myocardial injury. That is ensured by administering quinacrine intravenously in dose of 5 mg/kg for 10 minutes starting a minute before myocardial reperfusion begins.
EFFECT: method enables reducing the size of ischemic-reperfusion myocardial injury by reducing the myocardial necrosis zone with intravenous administration of quinacrine.
1 cl, 4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CARDIOPROTECTION OF ISCHEMIC AND REPERFUSION INJURIES IN ACUTE MYOCARDIAL INFARCTION | 2019 |
|
RU2712448C1 |
| AGENT SIMULATING CARDIAC POSTCONDITIONING PHENOMENON | 2012 |
|
RU2502508C1 |
| USE OF PHOSPHOLIPID EMULSION CONTAINING EFFECTIVE AMOUNT OF DIHYDROQUERCETIN FOR TREATING ISCHEMIA-REPERFUSION SYNDROME IN PATIENTS WITH ISCHEMIC ORGAN AND EXTREMITY INJURIES | 2021 |
|
RU2766681C1 |
| AGENT IMPROVING CARDIAC RESISTANCE TO ISCHEMIC AND FOLLOWING REPERFUSION INJURIES | 2012 |
|
RU2488404C1 |
| METHOD FOR MYOCARDIAL PROTECTION ACCOMPANYING CARDIOPULMONARY BYPASS SURGERY FOR AORTIC VALVE REPLACEMENT | 2013 |
|
RU2538044C1 |
| METHOD OF INTRAOPERATIVE VISUALIZATION OF ISCHEMIC-REPERFUSION DAMAGE OF MYOCARDIUM | 2016 |
|
RU2622983C1 |
| CARDIOPROTECTION TECHNIQUE | 2010 |
|
RU2456024C2 |
| AGENT HAVING CARDIOPROTECTIVE ACTION AND 1,3-DISUBSTITUTED 2-AMINOBENZIMIDAZOLIUM HALIDES | 2013 |
|
RU2526902C1 |
| APPLICATION OF GHRP-6 AS A CARDIOPROTECTIVE AND CARDIORESTORATIVE MEDICINAL PRODUCT FOR LATE TREATMENT | 2019 |
|
RU2779835C1 |
| APPLICATION OF KAURAN COMPOUNDS FOR MEDICINES PRODUCTION | 2004 |
|
RU2345761C2 |
